Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Blast Crisis 1

Interventions

venetoclax 190Cyclophosphamide 124Azacitidine 112Cytarabine 108fludarabine 92Specimen Handling 75Biopsy 54Daunorubicin 42Methotrexate 40Dexamethasone 37Rituximab 34blinatumomab 32Vincristine 31Decitabine 31fludarabine phosphate 30Injections 28Granulocyte Colony-Stimulating Factor 28Magnetic Resonance Spectroscopy 27Whole-Body Irradiation 26obinutuzumab 25Idarubicin 25acalabrutinib 23Mycophenolic Acid 23Prednisone 22Melphalan 21Busulfan 21gilteritinib 19Stem Cell Transplantation 19Doxorubicin 19ibrutinib 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Edetic Acid × Other hematologic neoplasm × Clear all
NCT03630991 2026-03-02

Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy

M.D. Anderson Cancer Center

Phase 1 Recruiting
58 enrolled
MyeloidOther hematologic neoplasm

Blast Crisis, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Myelodysplastic-Myeloproliferative Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡